인쇄하기
취소

Norvasc and Amaryl generics on hot competition.

Published: 2004-08-18 06:59:00
Updated: 2004-08-18 06:59:00
A competitive market entry of many patent expired products bursted into its flames in the market far earlier than expected.

Amrlodipine and Glipiramide generics successfully obtained the NHI reimbursement price approvals on Aug. 12 and therefore its NHI reimbursement will be effected from coming Sept. 1, thus the market competition of the anti-hypertensive and anti-diabetic drugs being flare...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.